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Abstract: Malignant catarrhal fever (MCF) is a rare but frequently lethal disease of certain cloven-
hoofed animals. At least 10 different viruses, all members of the macavirus genus in the subfamily
gammaherpesvirinae, are known as causative agents of MCF. Among these, Ovine herpesvirus 2 (OvHV-2)
is the most frequent and economically most important MCF agent. Phenotypically, MCF is characterized
by severe lymphocytic arteritis-periarteritis, which leads to the accumulation of activated lymphocytes,
accompanied by apoptosis and necrosis in a broad range of tissues. However, a viral factor that might be
responsible for the tissue damage has not yet been identified. We have studied a seemingly intergenic locus
on the OvHV-2 genome, which had previously been shown to be transcriptionally highly active in MCF-
affected tissue. We identified by 5’- and 3’ RACE a conserved, double-spliced transcript that encoded for
a 9.9 kDa hydrophobic protein. The newly detected gene, Ov8.25, and its splicing pattern was conserved
among OvHV-2 strains from different origins. Upon transient expression of synthetic variants of this
gene in various cell types, including bovine lymphocytes, the protein (pOv8.25) was shown to targeting
the mitochondria, followed by caspase-dependent apoptosis and necrosis. Notably, a deletion mutant of
the same protein lost these abilities. Finally, we detected pOv8.25 in brain-infiltrating lymphocytes of
cattle with MCF. Thus, the cell-death causing properties of pOv8.25 in affected cells may be involved
in the emergence of typical MCF-associated apoptosis and necrosis. Thus, we have identified a novel
OvHV-2 protein, which might contribute to the phenotype of MCF-related lesions.IMPORTANCEOvine
herpesvirus 2 (OvHV-2) circulates among sheep without causing disease. However, upon transmission
to cattle, the same virus instigates a frequently lethal disease, Malignant catarrhal fever (MCF). While
cause of death and pathogenesis of tissue lesions are still poorly understood, MCF is characterized by
accumulation of lymphocytes in various tissues, associated with vasculitis and cell death. As infectious
virus is hardly present in those lesions, the cause of cell death cannot simply be explained by viral
replication. The significance of our research is in identifying and characterizing a previously overlooked
gene of OvHV-2 (Ov8.25), which is highly expressed in animals with MCF. Its encoded protein targets
mitochondria, causing apoptosis and necrosis, thus, contributing to understand the source and nature of
cell death. As the corresponding genetic locus is also active in the context of MCF due to a different
Macavirus, we may have detected a common denominator of the disease phenotype.
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Abstract 22 
Malignant catarrhal fever (MCF) is a rare but frequently lethal disease of certain cloven-23 
hoofed animals. At least 10 different viruses, all members of the macavirus genus in the 24 
subfamily gammaherpesvirinae, are known as causative agents of MCF. Among these, 25 
Ovine herpesvirus 2 (OvHV-2) is the most frequent and economically most important 26 
MCF agent. Phenotypically, MCF is characterized by severe lymphocytic arteritis-27 
periarteritis, which leads to the accumulation of activated lymphocytes, accompanied by 28 
apoptosis and necrosis in a broad range of tissues. However, a viral factor that might be 29 
responsible for the tissue damage has not yet been identified. We have studied a 30 
seemingly intergenic locus on the OvHV-2 genome, which had previously been shown 31 
to be transcriptionally highly active in MCF-affected tissue. We identified by 5’- and 3’ 32 
RACE a conserved, double-spliced transcript that encoded for a 9.9 kDa hydrophobic 33 
protein. The newly detected gene, Ov8.25, and its splicing pattern was conserved 34 
among OvHV-2 strains from different origins. Upon transient expression of synthetic 35 
variants of this gene in various cell types, including bovine lymphocytes, the protein 36 
(pOv8.25) was shown to targeting the mitochondria, followed by caspase-dependent 37 
apoptosis and necrosis. Notably, a deletion mutant of the same protein lost these 38 
abilities. Finally, we detected pOv8.25 in brain-infiltrating lymphocytes of cattle with 39 
MCF. Thus, the cell-death causing properties of pOv8.25 in affected cells may be 40 
involved in the emergence of typical MCF-associated apoptosis and necrosis. Thus, we 41 
have identified a novel OvHV-2 protein, which might contribute to the phenotype of 42 
MCF-related lesions. 43 
IMPORTANCE 44 
Ovine herpesvirus 2 (OvHV-2) circulates among sheep without causing disease. 45 
However, upon transmission to cattle, the same virus instigates a frequently lethal 46 
disease, Malignant catarrhal fever (MCF). While cause of death and pathogenesis of 47 
tissue lesions are still poorly understood, MCF is characterized by accumulation of 48 
lymphocytes in various tissues, associated with vasculitis and cell death. As infectious 49 
virus is hardly present in those lesions, the cause of cell death cannot simply be 50 
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 3 
explained by viral replication. The significance of our research is in identifying and 51 
characterizing a previously overlooked gene of OvHV-2 (Ov8.25), which is highly 52 
expressed in animals with MCF. Its encoded protein targets mitochondria, causing 53 
apoptosis and necrosis, thus, contributing to understand the source and nature of cell 54 
death. As the corresponding genetic locus is also active in the context of MCF due to a 55 
different Macavirus, we may have detected a common denominator of the disease 56 
phenotype. 57 
Key words: Malignant catarrhal fever, MCF, Herpesvirus, Macavirus, Ovine herpesvirus 58 
2, OvHV-2, Ov8.25, pathogenesis, apoptosis, necrosis, mitochondria, disease 59 
phenotype. 60 
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 4 
Introduction 62 
Malignant catarrhal fever (MCF) is a rare but frequently lethal disease, affecting various 63 
species in the order Artiodactyla (even-toed cloven-hoofed animals). Two related 64 
viruses, Alcelaphine herpesvirus 1 (AlHV-1) and Ovine herpesvirus 2 (OvHV-2), both 65 
belonging to the macavirus genus within the subfamily gammaherpesvirinae, are 66 
responsible for most cases of MCF, although at least 8 additional MCF-causing viruses 67 
are known (reviewed in (1)). The economically most important form of MCF affects 68 
cattle as well as farmed bison and deer, occurs worldwide, and is associated to OvHV-69 
2. AlHV-1 also affects cattle but is restricted predominantly to Africa and to zoos (2-4).  70 
Typically, there are two types of host for the same virus, a reservoir host, among which 71 
the virus circulates without causing disease symptoms, and an indicator host, which is 72 
usually free of the same virus but succumbs to MCF upon accidental infection (1, 5-9). 73 
In the case of OvHV-2, sheep are the reservoir host, while the main range of indicator 74 
hosts includes various members of the bovinae, including cattle, water buffaloes and 75 
bison; the cervidae, including red deer and sika deer; the suidae, including the domestic 76 
pig (6, 10-17). 77 
Various clinical forms of the disease have been described but the so called “head and 78 
eye form” is most common, with typical signs including fever, inappetence, ocular and 79 
nasal discharge, corneal opacity, mucosal lesions in the buccal and nasal cavities and 80 
around the muzzle, diarrhea and depression. Up to 95% of affected cattle succumb to 81 
death or have to be euthanized within one week after the onset of the disease (6, 8, 12). 82 
Histologically, MCF is characterized by the accumulation of lymphocytes, apoptosis and 83 
necrosis in a range of tissues but the morphological hallmark is severe lymphocytic 84 
arteritis-periarteritis with affection of the tunica media (8, 18, 19). 85 
While viral transmission, clinical signs and histopathological changes associated with 86 
the disease have been well characterized, major aspects of the pathogenesis of MCF 87 
are still enigmatic. It is agreed, however, that both viral and host determinants play a 88 
role. Among the viral factors involved, it has been shown at least for AlHV-1 that 89 
expression of the latency-associated nuclear antigen (LANA) plays an essential role 90 
because a LANA-knock-out virus did not induce MCF (20). Based on this observation, it 91 
has been concluded that the infecting virus must be able to establish a latent infection 92 
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 5 
prior to the outbreak of the disease. However, the predicted properties associated to the 93 
LANA protein, which include maintenance of the viral genome during latency, cannot 94 
explain the disease phenotype. In the context of OvHV-2 such experiments have not yet 95 
been feasible because the virus can neither be propagated in conventional cell cultures 96 
nor is an infectious BAC-clone available that would make genetic engineering of the 97 
viral genome possible. However, there is ample evidence available, suggesting that the 98 
LANA gene (ORF73) is also expressed during MCF due to OvHV-2 (21). In addition, 99 
various reports have detected expression of OvHV-2 lytic genes throughout the course 100 
of the disease (22, 23). It has been debated, therefore, whether the lytic or the latent 101 
OvHV-2 may be responsible for the outbreak of MCF. As animals suffering from MCF 102 
typically do not shed and transmit the virus, it has also been agreed that OvHV-2 103 
replicates only poorly in the indicator animal species (1, 8, 24). Therefore, viral 104 
replication plays certainly an important role at very early stages of the infection, 105 
particularly prior to dissemination within the body. However, at later times, viral lytic 106 
genes may be transcribed and translated but certainly will not yield high viral titers. 107 
Indeed, typical herpesviral particles cannot consistently be found in affected tissues of 108 
animals with MCF but can be readily detected in nasal sheddings of seemingly healthy 109 
sheep excreting OvHV-2 (25, 26). Overall, no common denominator has yet been 110 
identified among the Macaviruses that might explain the occurrence and disease 111 
phenotype of MCF.  112 
In previous work, we have detected a genetic locus within the OvHV-2 genome with 113 
high transcriptional activity in lymphatic tissue of animals with SA-MCF (21). 114 
Interestingly, the same region in AlHV-1 was also transcriptionally active in tissues from 115 
animals with experimental AlHV-1 derived MCF (20). Hitherto, no gene has been 116 
allocated to this transcript, although the region in AlHV-1 has been designated E16 or 117 
ER16 (ER for expressed region), whereas we referred to the corresponding region in 118 
OvHV-2 as “intergenic” (20, 21). In the present work, we have mapped a previously 119 
overlooked viral gene, newly designated as Ov8.25, to this region, noting that it gives 120 
rise to a double-spliced mRNA, which translates into a small, hydrophobic protein. 121 
Transient expression of this protein (pOv8.25) showed that it targeted the mitochondria, 122 
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 6 
causing apoptosis and necrosis in transfected cells. Finally, pOv8.25 was also detected 123 
in the brain of cattle with MCF.  124 
Results 125 
Sequence of a novel transcript expressed in OvHV-2-infected cells  126 
In previous work (21), an RNA mapping to a seemingly intergenic region of the OvHV-2 127 
genome had been detected by microarray analysis in lymphnodes of cows with MCF. 128 
Here, RNA was extracted from two different sources in order to identify the ends of the 129 
predicted molecule by 5'-RACE and 3'-RACE as described in Materials and Methods. 130 
The first RNA-template originated from lymphocytes of a cow with MCF. The second 131 
RNA-template was extracted from OvHV-2-infected large granular lymphocytes (LGLs).  132 
The products of the RLM-RACE PCR were loaded on a 1% agarose gel (Fig. 1). After 133 
nested amplification, the 5`end provided a product of approximately 400 bp (lane 4), 134 
whereas the 3`end resulted in a 200 bp product (lane 2). Similar results were obtained 135 
with the second template (data not shown).  136 
The PCR products were cloned using the TOPO-TA method and submitted for 137 
sequencing. Interestingly, the sequences obtained from the two independent sources 138 
were 96% identical. The sequences were then aligned to the OvHV-2 genomes 139 
published in GenBank (AY839756, a Scotch strain, derived from bovine LGLs; 140 
DQ198083, an American strain, derived from sheep nasal secretions). The 5'-end of the 141 
transcript from the cow with MCF mapped to position 114706 of the Scotch strain, which 142 
corresponds to position 114555 of the American strain. The 3'-end mapped to the 143 
positions 115450 (Scotch strain) and 115287 (American strain), respectively. From 144 
these map positions, a transcript size of between 745 (Scotch strain) and 733 bases 145 
(American strain) could be predicted. However, the observed transcript size was less. It 146 
was also evident that there were two parts in the OvHV-2 genomes, which were not 147 
detected in the transcripts. The most probable explanation for these gaps was a splicing 148 
process executed on the primary transcript. Indeed, upon in silico analysis of the 149 
transcript's sequence, the NetGene2 Server confirmed the observed splice sites with 150 
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 7 
good statistical confidence (www.cbs.dtu.dk/services/NetGene2) (see Fig. 2). 151 
Significantly, the predicted splice sites were conserved in all four sequences.  152 
 153 
The novel transcript is spliced upon transient expression  154 
The genomic locus encompassing the two putative introns was amplified by PCR and 155 
cloned under the control of the cmvIE promoter into the pEGFP N3 vector for transient 156 
expression assays. HEK 293T cells were transfected with this construct and total RNA 157 
was harvested at 25 hrs post transfection. After reverse transcription, the cDNA was 158 
PCR amplified by using primers corresponding to the terminal OvHV-2 sequences of the 159 
construct. Input DNA was used as a positive control. Fig. 3 shows the results. The DNA 160 
template provided a PCR product of just below 400 bp, which corresponded well with 161 
the expected size of 364 bp (lane 5). In contrast, the cDNA template (lanes 2, 3, 4) 162 
provided one strong band at approximately 200 bp and two weaker bands; the upper 163 
migrating as the unspliced DNA template and the second at an intermediate position, 164 
just below 300 bp. The strong band was consistent with the predicted size (177 bp) of 165 
the double-spliced transcript, which was verified by extracting the band from the gel 166 
followed by sequencing. The intermediate band may represent a single-spliced variant. 167 
Thus, splicing of the transiently expressed transcript took place, even in the absence of 168 
other factors contributed by OvHV-2. Based on these results, we concluded that the 169 
afore-mentioned "intergenic" region of the OvHV-2 genome was by no means 170 
"intergenic". Rather, it comprised a thus far overlooked OvHV-2 gene. BLAST analysis 171 
did not reveal similar genes in other herpesviruses. Therefore, we considered it as an 172 
OvHV-2-specific gene. Due to its location on the OvHV-2 genome, in between ORF69 173 
and Ov8.5, the novel gene was named Ov8.25.  174 
Ov8.25 encodes a protein  175 
To address the novel gene's capacity to encode for a protein, the afore-mentioned 176 
cDNA was PCR amplified by using primers that targeted the Ov8.25 sequence 177 
beginning from the predicted ATG of the putative open reading frame (ORF) down to 178 
the 3'-end of the ORF but without the STOP codon. This amplified sequence was then 179 
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 8 
cloned into an HSV-1 amplicon vector, which also provided a C-terminal yellow 180 
fluorescence protein (EYFP) as a fusion partner for the putative Ov8.25 protein. The 181 
resulting construct was transfected into Vero 2-2 cells and analyzed under the 182 
fluorescence microscope at 24 hrs post transfection. As shown in Fig. 4A, an EGFP-183 
expressing control amplicon construct illuminated the body of transfected cells with 184 
green fluorescent protein. In contrast, as shown in Fig. 4B, the putative pOv8.25-EYFP-185 
fusion protein localized to the cytoplasm, predominantly around the rim of the cellular 186 
nucleus. It was noted that cells expressing the newly detected protein showed quite 187 
often an enlarged nucleus. Moreover, the yield of pOv8.25 protein seemed to be low.  188 
Splicing of the Ov8.25 transcript is independent of its protein-coding sequences  189 
The putative function of the Ov8.25 locus might be associated either to the encoded 190 
protein or to splicing of the primary transcript or else even to both features. In order to 191 
discriminate between these possibilities, synthetic constructs as described in Tab. 3 192 
were generated. The five constructs were separately transfected into Vero 2-2 cells and 193 
RNA was harvested after 24 hrs. Each RNA extract was reverse transcribed into cDNA 194 
before amplifying the sequences of interest by PCR as described in Materials and 195 
Methods. As shown in Fig. 5., the transiently expressed transcript was spliced even 196 
when the amino acid coding sequences had been optimized for translation in Bovine 197 
cells (lane 3) or when protein translation was abolished after removing all start codons 198 
(ATG) from within the coding sequences and replacing them by stop codons (lane 6). 199 
The same extracts amplified without prior treatment with reverse transcriptase (lanes 4 200 
and 7) did not yield a product. In contrast, when the corresponding plasmid DNA was 201 
used as PCR template, a larger band became visible (lanes 2 and 5), where the size 202 
difference could be explained by the size of the introns. Similarly, the single intron 203 
constructs were spliced as shown in lanes 9 and 12 (corresponding controls in lanes 8, 204 
10 and 11, 13, respectively). In contrast to all of those constructs, the synthetic 205 
intronless construct remained unspliced (lanes 15 to 17).  206 
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 9 
Primary characterization of the pOv8.25-EYFP fusion protein  207 
According to its amino acid sequence and although it did not feature a signal sequence, 208 
the Ov8.25 protein (pOv8.25) was predicted to be a membrane protein (Fig. 6) with two 209 
transmembrane domains and a predicted molecular weight of 9.9 kDa. In the absence 210 
of existing antibodies against pOv8.25, the encoded translation product was first 211 
characterized as a EYFP fusion protein.  212 
To this end, Vero 2-2 cells were transfected with amplicon vectors encoding either 213 
EYFP alone or EYFP as C-terminal fusion protein to pOv8.25. 24 hrs after transfection, 214 
yellow fluorescence was observed in approximately 50% of the cells, which were then 215 
harvested for analysis by Western immunoblot using a monoclonal antibody against 216 
GFP (Fig. 7A). EYFP was expected to migrate at approximately 26,9 kDa and the 217 
pOv8.25-EYFP fusion protein at 38,8 kDa. However, a second, faster migrating band of 218 
approximately 33 kDa was visible in lane 2 but absent in lane 3. The size of this 33 kDa 219 
band corresponds well to the predicted molecular weight of an N-terminally truncated 220 
Ov8.25-EYFP fusion protein, whose translation would start only at the second 221 
methionine-codon (position M51). Such a truncation would remove the predicted 222 
transmembrane domains of pOv8.25, which might interfere with its subcellular 223 
localization and biological function. Interestingly, also slower migrating bands at about 224 
70 kDa were stained by the anti-GFP antibody in each of the two Ov8.25-transfected 225 
extracts in lanes 2 and 3 (Fig. 7A). The same extra bands were also visible in the 226 
insoluble extract (Fig. 7B), where, even an additional 48 kDa band emerged. These 227 
higher bands were not visible in the EYFP extract, the non-transfected cell extract (lane 228 
4), or the soluble cell extracts (Fig. 7C). The nature of these bands cannot yet be 229 
rationally explained. Yet, potential reasons may include dimerization or covalent binding 230 
to a host protein. 231 
In order to address the nature of the 33 kDa band that was only visible in extracts from 232 
cells transfected with the codon-optimized, intronless Ov8.25 coding sequence, two 5’-233 
deletion mutants were constructed, one yielding a 5'-truncated codon-optimized Ov8.25 234 
locus with C-terminal EYFP, the other giving a 5'-truncated codon-optimized, intronless 235 
Ov8.25 coding sequence with C-terminal EYFP. Both constructs had their translation 236 
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 10 
initiation codon at the previous position 51 (M51, see Fig. 6), which caused a loss of the 237 
membrane anchoring of the truncated protein. Accordingly, we hypothesized that the 238 
truncated proteins may be more soluble than their original counterparts. To address this 239 
issue, cells were transfected with either the original constructs or their truncated counter 240 
parts. Non-transfected cell and cells transfected with the EYFP amplicon served as 241 
controls. After harvesting, the cells were suspended in a buffer containing Triton X-100 242 
before soluble and insoluble components were separated by centrifugation. Soluble and 243 
insoluble extracts were separated by SDS-PAGE, transferred to Western blots and 244 
stained using the anti-GFP mcAb. The results are shown in Fig. 7, panels B and C. By 245 
itself, EYFP divided almost uniformly into the soluble and the insoluble fractions (lanes 2 246 
in panels B and C). However, a fainter and faster migrating band was additionally 247 
observed in the soluble fraction (lane 2, panel C). In contrast, the full length Ov8.25 248 
fusion proteins accumulated predominantly in the insoluble fraction (lanes 3, 4 in panel 249 
B). Indeed, the high molecular weight bands were readily detected in the insoluble 250 
fractions but invisible in the soluble fractions (lanes 3, 4 in panel C). However, the 251 
predicted 38,8 kDa band was discernible in both fractions. Interestingly, the M51-252 
truncated proteins were not detected in the insoluble fractions (lanes 5 and 6 in panel B) 253 
but were readily discernible among the soluble proteins (lanes 5 and 6 in panel C). The 254 
33 kDa protein produced in cells transfected with the codon-optimized, intronless 255 
Ov8.25 coding sequence was not seen among the insoluble proteins (lane 4 in panel B) 256 
but sided entirely to the soluble fraction (lane 4 in panel C). Moreover, it migrated at the 257 
same velocity as the truncated versions of pOv8.25, which was consistent with the 258 
hypothesis that it actually represented a secondary translation product of the codon-259 
optimized fusion protein, which used M51 as its start codon. Since actin, shown in panel 260 
A’ migrated very close to the fusion proteins of interest, we used the slower migrating 261 
tubulin as a loading control. The blots B and C were re-stained, using a monoclonal 262 
antibody against tubulin. The immunoblots B’ and C’ clearly demonstrate that a major 263 
part of tubulin went into the soluble fraction, although enough tubulin was retained in the 264 
insoluble fraction to show that comparable amounts of cell extracts had been loaded in 265 
each lane.  266 
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 11 
Identification of the Ov8.25 protein by antibodies to synthetic peptide 267 
To open the possibility of recognizing the Ov8.25 protein in its native form, without tag, 268 
rabbits were immunized with a synthetic peptide, which had been predicted to represent 269 
an immunogenic part of pOv8.25, namely spanning from aa 60 to 76 of the predicted 270 
protein (see Fig. 6). Vero cells were transfected either with the EYFP amplicon or the 271 
codon-optimized, intronless Ov8.25 coding sequence with C-terminal EYFP or the 272 
codon-optimized Ov8.25 locus with C-terminal EYFP or, as a negative control, they 273 
were left untransfected. Furthermore, the truncated versions of the two Ov8.25 fusion 274 
proteins were also included in the experiment. After 24 hrs, the cells were harvested 275 
and the insoluble fractions were subjected to SDS-PAGE and Western transfer. 276 
Identical blots were either immunostained with the rabbit anti-pOv8.25 peptide serum or 277 
with anti-GFP mcAb. The results are shown in Fig. 8. As expected, the rabbit anti 278 
peptide serum (panel A) was able to stain the predicted 38.7 kDa pOv8.25-EYFP fusion 279 
proteins (lanes 3, 4) but did not react with EYFP alone (lane 2) or with non-transfected 280 
Vero cells (lane 1). As expected, the truncated forms of pOv8.25 were not detected on 281 
the blot, since they had been removed with the soluble fractions.  282 
Moreover, the rabbit anti-peptide serum recognized also the higher molecular bands in 283 
lanes 3 and 4 of panel A, the one migrating just above 70 kDa. Bands of much the same 284 
sizes were also recognized by the anti-GFP mcAb in lanes 3 and 4 (panel B). 285 
Importantly, the rabbit anti-peptide serum did no longer react with the same proteins if it 286 
was saturated with the immunizing peptide (panel C). Together, these data suggest that 287 
the anti-peptide serum actually recognized the pOv8.25-fragment of the fusion protein 288 
and that this protein existed in at least two forms in transfected cells, namely in a 289 
monomeric form with the expected size of 38.7 kDa and in higher molecular forms of 290 
>70 respectively. 291 
The pOv8.25-EYFP fusion protein targets mitochondria  292 
As the pOv8.25 protein had been observed to assume a cytoplasmic localization (Fig. 293 
4), it was of interest to know, where exactly this could be. Analysis of its amino acid 294 
sequence (Fig. 6) did reveal two potential transmembrane domains (aa 13-32 and aa 295 
37-56). Moreover, a BPD_transp_1 domain had been predicted for aa 9 to 31. All of this 296 
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 12 
in silico information suggested that pOv8.25 may represent a membrane protein, 297 
although a classical signal sequence was not identified.  298 
Confocal microscopy was used to address this issue. Vero cells were transfected with 299 
Ov8.25-EYFP amplicon DNA. Separate samples were harvested at 6, 24, and 48 hrs 300 
post transfection and stained with fluorescent markers for individual membranous 301 
compartments, i.e. Mitotracker to test co-localization with mitochondrial membranes, 302 
ConA to make the ER compartment visible, and WGA to visualize the Golgi 303 
membranes. As shown in Fig. 9, pOv8.25-EYFP (panels A,C and D,F) co-localized with 304 
the mitotracker stain (panels B,C and E,F), which was corroborated by reconstructing 305 
the three-dimensional structure of the cell (panel C’). As a control, an N-terminally 306 
truncated version of pOv8.25 (TOv8.25CDS-EYFP; starting at M51) was analyzed in the 307 
same manner but did not co-localize with a particular subcellular structure (panels G,I). 308 
Thus, an intact pOv8.25 was required to achieve the particular subcellular localization of 309 
the fusion protein.  310 
Moreover, the results shown in Fig. 10 indicated that pOv8.25-EYFP indeed co-311 
localized predominantly but not exclusively with the mitochondria. At 48 hrs a significant 312 
co-localization with the ER membranes was also noted. In contrast, co-localization with 313 
Golgi membranes was not detected under the present experimental conditions.  314 
The pOv8.25-EYFP fusion protein induces cell death in a bovine lymphocyte cell line  315 
The previous observations that cells expressing the newly detected protein showed 316 
quite often an enlarged nucleus and that the yields of pOv8.25-EYFP protein always 317 
seemed to be low obtained a new significance, when co-localization of the protein with 318 
the mitochondrial membranes was observed. Accordingly, we hypothesized that 319 
pOv8.25 may induce cell death. To test this hypothesis and to see, whether or not this 320 
was the case in bovine lymphocytes, we made use of Tp951-f53, a previously 321 
characterized Theileria parva-transformed Bovine cell line (30), which was triple positive 322 
for CD4, CD25, and FoxP3, thus, carrying the markers of regulatory T-cells (Tregs). 323 
Accordingly, Tp951-f53 cells were non-transduced or transduced with either Ov8.25L-324 
EYFP or Ov8.25cds-EYFP or, as a negative control, with a GFP construct. After 24 hrs, 325 
the cells were stained with annexin-V (A-V) and propidium iodide (P.I.) and successfully 326 
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transduced cells were gated according to their fluorescence before analysis their status 327 
concerning A-V and P.I. by FACS. The results, are shown in Fig. 11. Non-transduced 328 
cells (Fig. 11A) were used to set the cut-off for fluorescing cells in gate C. Although the 329 
transfection rate was not high, fluorescent cells could be detected in panels B, C, and D. 330 
These fluorescent cells in gate C were analyzed for their A-V and P.I. status. As shown 331 
in panel B, 45% of the GFP-transduced cells were double negative for A-V and P.I., 332 
whereas 52% were double-positive. However, upon transduction with the Ov8.25 333 
constructs, the ratio of double positive cells amounted to nearly 99%, with only few cells 334 
remaining viable.  335 
We concluded from these observations that indeed pOv8.25 may induce cell death, 336 
even in an immortalized bovine lymphocyte cell line.  337 
Investigating into the pathway of pOv8.25-mediated cell death  338 
In order to address the pathway of pOv8.25-mediated cell death, Vero 2-2 cells were 339 
transfected with Ov8.25-EYFP constructs or, as controls, with the N-terminally truncated 340 
Ov8.25-EYFP constructs or with EYFP alone. Replicate cultures were harvested at 48 341 
and 72 hrs post transfection and double-stained with annexin V (AV) and propidium 342 
iodide (PI) prior to analysis by FACS. The results, showing EYFP-gated cells, are 343 
presented in Fig. 12.  344 
Upon transfection, cell viability decreased over time, even with the three control 345 
constructs (EYFP, TOv8.25_EYFP, TOv8.25CDS_EYFP). Yet, at 48 hrs post 346 
transfection with these controls, 67 to 70% of the cells remained viable. In contrast, only 347 
41 to 43% of the cells transfected with intact Ov8.25-EYFP remained viable. At 72 hrs 348 
the viable cells were further reduced with 45-55% remaining viable upon transfection 349 
with the control constructs but only 20% cells surviving upon transfection with intact 350 
Ov8.25. Moreover, the proportion of Annexin V-positive but PI-negative cells at 48 hrs 351 
post transfection amounted to approximately 40% with cells transfected with intact 352 
Ov8.25, whereas only around 20% of the controls were positive for this marker of 353 
apoptosis. At 72 hrs post transfection, the proportion of Annexin V-positive but PI-354 
negative cells remained almost stable with the controls (20-30%), while it actually 355 
decreased with the cells transfected with intact Ov8.25 (26-29%). In contrast, the 356 
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proportion of double-positive cells was two to three-fold higher in cells transfected with 357 
intact Ov8.25 (48-50%) compared to the controls (11-21%). 358 
Thus, cells transfected with intact Ov8.25 went into apoptosis (AV-positive/PI-negative) 359 
at around 48 hrs post transfection and showed predominantly signs of late apoptosis 360 
(AV and PI-double positive) at 72 hrs post transfection.  361 
pOv8.25-mediated cell death inhibited by caspase inhibitors  362 
Having established that pOv8.25 targeted mitochondria and that successfully 363 
transfected cells showed consecutively signs of early and late apoptosis, it was of 364 
interest to test, whether or not this effect could be inhibited by caspase inhibitors. 365 
Similar to the previous experiment, Vero 2-2 cells were transfected with Ov8.25-EYFP 366 
constructs or, as a negative control, with EYFP alone. Replicate cultures were 367 
incubated either in the presence or the absence of a pan-caspase inhibitor, Z-VAD-368 
FMK. Replicate cell cultures were harvested at 48 and 72 hrs post transfection and 369 
double-stained with AV and PI prior to analysis by FACS. The experiment was repeated 370 
five times and, despite of varying transfection efficiencies (Fig. 13A), always with the 371 
same outcome, namely increased cell death in the presence of the Ov8.25 protein (Fig. 372 
13 B through E). Both at 48 and 72 hrs, the proportion of live cells (AV/PI-double 373 
negative) among Ov8.25-transfected cells was significantly reduced compared to EYFP-374 
transfected cells (Fig. 13B,C). However, in the presence of caspase inhibitors, the 375 
viability of Ov8.25- and EYFP-transfected cells was not significantly different. 376 
Interestingly, the predominant phenotype of non-viable cells at 48 hrs differed from that 377 
at 72 hrs. At 48 hrs, early apoptotic cells (AV-positive/PI-negative) were significantly 378 
increased among Ov8.25-transfected cells without caspase inhibitors compared to 379 
either EYFP-transfected cells, independent of caspase inhibitors, or else Ov8.25-380 
transfected cells in the presence of caspase inhibitors (Fig. 13D). However, at 72 hrs, 381 
late apoptotic cells (AV/PI double positive) made a similar, highly significant difference 382 
between Ov8.25-transfected cells without and Ov8.25-transfected cells with caspase 383 
inhibitors or EYFP-transfected cells, independent of presence or absence of inhibitors 384 
(Fig. 13E). A general loss of viable cells observed at 72 hrs compared to 48 hrs post 385 
transfection was attributed to stressing the cells due to the transfection protocol.  386 
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Thus, the cell death induced following transient expression of pOv8.25 was indeed due 387 
to caspase-dependent cell death.  388 
Detection of pOv8.25 in brain-infiltrating lymphocytes of cattle with MCF. 389 
Based on the previous results, it was of interest to test, whether or not pOv8.25 was 390 
detectable in pathognomonic lesions of cattle with MCF. Due to the scarcity of fresh 391 
cases, historic samples of cattle with histologically confirmed encephalitis were used for 392 
this purpose. Indeed, immunohistological signals of pOv8.25 were detected among 393 
infiltrating lymphocytes in brain sections of two of those cases (Fig. 14A,B). The same 394 
signals remained undetectable upon prior saturation of the antiserum with the 395 
immunizing peptide. Although they comprised histologically similar brain lesions, the 396 
other two cases, which had previously deemed OvHV2-negative by PCR, did not show 397 
any detectable pOv8.25 (Fig. 14C,D). Thus, as a proof of principle, pOv8.25 could be 398 
detected within typical MCF lesions.  399 
Discussion 400 
In this communication, we describe a previously overlooked gene of OvHV-2, which was 401 
only noticed because of its abundant expression in animals with MCF (21). In lymphatic 402 
tissues of such animals as well as in persistently infected cell cultures (LGL) and upon 403 
transient expression in transfected or transduced cells, this newly identified gene is 404 
expressed as a double spliced mRNA. This gene, termed Ov8.25 due to its location 405 
within the OvHV-2 genome, encodes for a protein (pOv8.25) that targets the 406 
mitochondria in a manner to inducing apoptosis and necrosis.  407 
There are several distinct viruses that cause clinically and histopathologically very 408 
similar illnesses, all of them believed to represent the same disease, MCF. These 409 
viruses are genetically similar among each other and taxonomically grouped together in 410 
the genus Macavirus of the subfamily Gammaherpesvirinae, yet each one of them has 411 
also a number of specific genes that discriminate these viruses as a group from the 412 
other genera of the gammaherpesviruses and at the individual level each member from 413 
the other members of the genus (1, 21, 31). These genes are named in relation to the 414 
virus they belong to, for example A1 through A10 in the case of AlHV-1 or, respectively, 415 
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Ov2 through Ov10 in the case of OvHV-2. The nomenclature stems from the sequence 416 
of AlHV-1, which had been published first and is, therefore, recognized as the prototype 417 
(32). The numbering was from left to right on the original sequence. Later on, additional 418 
members of these specific genes were detected, which led to the introduction of “0.5” 419 
nomenclature, depending on the relative position of the newly detected gene among the 420 
original enumeration (8, 33, 34). For example, A4.5 was designated as such for its 421 
position in between of A4 and A5. The Ov-nomenclature was then adopted to use the 422 
same enumeration for potential orthologues to particular A-genes in OvHV-2 (33, 34). 423 
For example, a potential orthologue to A1 was not detected in the OvHV-2 sequence. 424 
Consequently, OvHV-2 has no Ov1. However, the first OvHV-2-specific gene was 425 
termed Ov2 for its similarity to A2. Moreover, the OvHV-2 genome has an additional 426 
specific gene in between of Ov2 and Ov3, which was designated Ov2.5 (35). Based on 427 
these considerations and the map location of the newly detected gene in between of 428 
Ov8 or, more narrowly ORF69, and Ov8.5, we named it Ov8.25. Interestingly, the 429 
Ov8.25 gene is not only conserved among various OvHV-2 isolates (Fig. 2) but has also 430 
a positional homologue in AlHV-1, termed expressed region 16 (ER16), which is highly 431 
transcribed during experimental MCF (20). Of note, a small open reading frame within 432 
ER16 has the capacity to encode for an 11.3 kDa hydrophobic protein with two 433 
transmembrane regions, which shares a PVQC-motif near its C-terminus with our newly 434 
detected pOv8.25. Thus, this genomic locus and its protein may be one of the important 435 
players in the pathogenesis of MCF, which is, despite of recent progress, still not fully 436 
understood (8, 21, 36-39). However, it remains to be confirmed that an orthologue to 437 
this gene exists also in other Macaviruses. 438 
Based on recent evidence, it can be assumed that the main portal of entry of OvHV-2 439 
into cattle is by the respiratory route and relies on at least a few rounds of lytic 440 
replication of OvHV-2 in deep lung tissue (23, 40). Later on, OvHV-2 -- as well as AlHV-441 
1 -- is disseminated systemically in the infected organism, affecting different types of 442 
peripheral blood mononuclear cells (PBMC), particularly lymphocytes, but remaining 443 
now in a predominantly latent form of the infection as evidenced by viral gene 444 
expression assays (20, 21, 41). With the onset of clinical symptoms, a loss of overall 445 
lymphocyte counts goes along with the histological picture of non-purulent inflammation, 446 
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apoptosis and necrosis not only of lymphoid tissue but also of blood vessels in various 447 
organs due to accumulation of activated T-cells (8). Our finding that pOv8.25 targets the 448 
mitochondria to induce apoptosis and necrosis fits in very well with these 449 
histopathological findings in animals with MCF. The detection of pOv8.25 in infiltrating 450 
lymphocytes within typical MCF lesions (Fig. 14) supports this notion as a proof of 451 
principle.  452 
In the light of our present findings, we speculate that particularly the pronecrotic 453 
property of pOv8.25 (Fig. 12) might contribute to the severity and perpetuation of the 454 
disease: expression of pOv8.25 in various cell types, thus, causing their apoptosis and 455 
necrosis will facilitate extravasation of PBMC and, since they are also infected and 456 
expressing Ov8.25, generation of necrotic foci around such vessels might eventually 457 
attract an inflammatory reaction. In this context, it was important to show that a 458 
truncated form of pOv8.25 had lost its ability to target the mitochondria (Fig. 9) and, 459 
consequently failed in its pronecrotic facility (Fig. 12). Moreover, we were able to 460 
demonstrate that the killing activity of pOv8.25 does extend even to seemingly 461 
immortalized bovine lymphocytes with a Treg phenotype (Fig. 11), whose regulating 462 
activity would be much needed to curb the destructive effects of activated killer cells. 463 
Our results also shed a new light on the old debate about the roles of the latent or 464 
proliferative forms of the virus throughout the disease. In AlHV-1 it has been firmly 465 
established that an intact ORF73, encoding the major latency associated nuclear 466 
antigen (LANA), is essential for the development of WA-MCF (20). It has not been 467 
possible to establish the same for OvHV-2 and SA-MCF because, due to its inability to 468 
replicate in conventional cell cultures, there has not yet been any success in genetically 469 
modifying OvHV-2. However, a less strictly regulated gene expression pattern during 470 
MCF has been observed with OvHV-2 as compared to AlHV-1 (reviewed in (1)). Indeed, 471 
the transcripts of several lytic OvHV-2 genes have consistently been observed in MCF 472 
lesions, among others, the transcript for the major capsid protein, which is encoded by 473 
ORF25 (23). In the rabbit model, the lytic proteins encoded by ORF43 and ORF67 could 474 
directly be detected within MCF lesions by using specific antisera (22). However, these 475 
observations are contrasted by the absence of demonstrable viral particles in the 476 
lesions of clinically affected animals (1, 42, 43).  477 
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Unresolved issues. (1) From our Westernblots (Fig. 7), we gained the suspicion that 478 
pOv8.25 either interacts covalently with at least one host protein or is able to form 479 
homopolymers. It was beyond the scope of this work to address this issue further but it 480 
would be highly interesting to know the putative interaction partners of pOv8.25. (2) It is 481 
well accepted that viruses do not carry genes for no purpose. Therefore, we have to 482 
assume that the Ov8.25 locus, its protein as well as potentially its introns play a role in 483 
the natural life cycle of OvHV-2 among sheep. Understanding this role would be very 484 
helpful for considering what goes wrong to cause MCF in the indicator host. It might be 485 
possible to address this issue in the future, provided that a BAC-cloned OvHV-2 would 486 
be available. (3) As we recognize that Ov8.25 seems to be important enough for OvHV-487 
2 to keep it conserved among vastly different isolates (Scotch, American, Swiss; Fig. 2), 488 
we have to assume as well that it is expressed throughout replication and/or latency in 489 
sheep. Yet, its true function remains obscure.  490 
 491 
Conclusions. We have characterized a previously overlooked genetic locus in OvHV-2, 492 
which is conserved among viruses causing Malignant catarrhal fever and highly 493 
transcribed throughout disease. In OvHV-2, the transcript is double spliced, giving rise 494 
to a short protein with two transmembrane regions, which targets the mitochondria, 495 
causing apoptosis and necrosis in various cell types and which can be detected in 496 
affected brain tissue. An N-terminal truncation of this protein abrogates its proapoptotic 497 
properties. With Ov8.25 mRNA (21) and its encoded protein with its newly reported 498 
properties present in MCF lesions, we may now begin to understand some destructive 499 
aspects of the disease phenotype. We even speculate that pOv8.25 might represent an 500 
important trigger for the development of MCF.  501 
 502 
Materials and Methods 503 
Ethic statement and animals.  504 
The study did not require anesthesia, euthanasia, or any kind of animal sacrifice. 505 
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Samples from animals with MCF. 506 
Lymphocytes from a Swiss cow with OvHV-2 associated MCF were kindly provided by 507 
Dr. Marco Franchini (University of Zurich, Switzerland).  508 
 509 
OvHV-2-infected large granular lymphocytes (LGLs). 510 
Persistently OvHV-2-positive LGL were kindly provided by Dr. George Russel, Moredun 511 
Research Institute, Edinburgh, Scotland. 512 
 513 
RLM-RACE and cloning 514 
RNA Ligase Mediated Rapid Amplification of cDNA Ends (RLM-RACE) 515 
Total RNA was extracted from OvHV-2-positive materials and 2 to 5 µg were used for 516 
RLM-RACE (Ambion FirstChoice RLM-RACE Kit from Thermo Fisher Scientific). The 517 
protocol followed essentially the supplier’s recommendations. Briefly, for 5’ RACE, 518 
RACE adapters were ligated to the targeted RNA templates before reverse transcription 519 
was initiated using a sequence-specific reverse primer. The cDNA was then used for 520 
nested PCR. For 3’ RACE, reverse transcription was started from the 3’ RACE adapter, 521 
whereas the consecutive nested PCR needed a pair of sequence-specific forward 522 
primers, bracketing the targeted sequence with a pair of reverse primers provided in the 523 
kit. Eventually, these PCRs provided enough amplification product for cloning and 524 
sequencing. The primers used are listed in Table. 1.  525 
Cloning of the Ov8.25 locus into pEGFP N3 526 
The newly determined Ov8.25 locus was amplified by bracketing PCR primers (Table. 527 
2), which were supplemented with specific restriction enzyme digestion sites for later 528 
orientation-dependent subcloning. The ensuing 750 bp PCR product was initially cloned 529 
into the TOPO TA vector. After verifying its desired sequence, the desired fragment was 530 
excised from the TOPO vector by double digestion with NheI and EagI, whereas the 531 
pEGFP-vector was opened by NheI and NotI digestion. After agarose gel 532 
electrophoresis, the desired fragments were cut out, pooled, and liquefied for in-gel-533 
ligation, using 1 μl of the vector (gel), 4 μl of the DNA fragment/insert (gel), 1 μl T4 DNA 534 
ligase, 2.5 μl T4 DNA buffer, and nuclease-free H2O to give a final volume of 26 μl. 535 
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Sequencing of the ensuing cloned construct confirmed that the Ov8.25 locus was now 536 
in the pEGFP N3 vector and under the control of the cmvIE promoter.  537 
Synthetic constructs 538 
Synthetic DNA sequences were obtained from GenScript (Piscataway, NJ, U.S.A.). The 539 
Gateway Technology (Invitrogen/Thermo Fisher Scientific) was used to transfer the 540 
synthetic constructs into pHSV-amplicon vectors, whose design has been described 541 
(27). A summary of the constructs is provided in Table. 3.  542 
Cell culture 543 
Vero 2-2 cells are derived from African green monkey Vero kidney epithelial cell line by 544 
incorporating a plasmid containing the IE2 (ICP27) gene and promoter into the genome. 545 
Vero 2-2 cells were cultured in DMEM (Life Technologies) containing 10% heat 546 
inactivated fetal bovine serum FCS, geneticin (500 μg/ml). Cells were cultured at 37°C 547 
in a humidified atmosphere containing 5% CO2.  548 
HEK 293T cells were obtained from ATCC and are human embryonic kidney cells, 549 
which contain Adeno and SV-40 viral DNA sequences and which are particularly 550 
suitable for transient expression assays. These cells were also kept in DMEM, 551 
propagated with FCS and kept in 5% CO2. 552 
Theileria-Parva (T.p) transformed bovine T-lymphocytes (generously gifted by late 553 
Prof. Dobbeleare, Institute of molecular parasitology, University of Bern) were cultured 554 
in RPMI 10% heat inactivated fetal bovine serum (FBS) (10500-064, GIBCO), 1% 555 
penicillin/streptomycin and 0.001% ß-Mercaptoethanol (60242, SIGMA-ALDRICH). 556 
Cells were cultured at 37°C in a humidified atmosphere containing 5% CO2. Tp951-f53: 557 
Cell line clone of PBMCs of animal 951 which were infected with T. p. Marikebuni, 558 
(CTVM, stabilate 72) of genotype F53 and cloned by limiting dilution. Tp951-f31. Cell 559 
line clone of PBMCs of animal 951 which were infected with T. p. Marikebuni, (CTVM, 560 
stabilate 72) of genotype F31 and cloned by limiting dilution.  561 
Transient expression 562 
For transient expression, cloned DNA was transfected using Lipofectamin LTX into 563 
either HEK 293T or Vero 2-2 cells. 48 h after transfection, total RNA was extracted 564 
using the RNeasy mini kit (QIAGEN), Hombrechtikon, Switzerland. The extracted RNA 565 
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was reverse transcribed using the reverse transcription protocol of Promega. The 566 
phusion high- fidelity DNA polymerase (FINNZYMES, Thermo Fisher Scientific, 567 
Reinach, Switzerland) was used to amplify the cDNA by PCR, using primers (listed in 568 
Tab. 2), which bracketed the introns of interest. The amplified PCR products were then 569 
run on 2% agarose gel (NEEO ultra quality agarose, ROTH AG, Arlesheim, 570 
Switzerland).  571 
Polyacrylamide gel electrophoresis and Western transfer 572 
Post 24 h of transfection, the cells were washed once with PBS before 160 μl of IP 573 
buffer (1% Triton-X100, 20 m M Tris, 50 mM Nacl, 50 mM NaF, 150 mM Na4P2O7, 10 574 
mM EDTA) was added. The cells were then scrapped off and transferred into a 1.5 ml 575 
Eppendorf tube to be incubated on ice for 15 min. The lysate was then centrifuged in an 576 
Eppendorf centrifuge for 15 min at 13000 rpm and at 4°C. The soluble (supernatant) 577 
and insoluble (cell pellet) fractions were separated in two tubes. The cell pellet was re-578 
suspended in 84 μl of PBS and mixed with 16 μl of 6x Lämmli buffer whereas 33 μl of 6x 579 
Lämmli buffer was added to the supernatant and boiled for 10 min at 95°C. The protein 580 
lysates were run in 15% of polyacrylamide gels at 100 V for 2 hrs before being 581 
transferred onto PVDF membranes (BIO-RAD) at 100 V for 1.5 hrs. 582 
Fluorescence microscopy and confocal microscopy 583 
Separate dishes of transfected cells were incubated at 37°C for 6, 24 or 48 h, 584 
respectively. In order to stain mitochondria, after each incubation time, cells were 585 
washed 1X with PBS before mitotracker deep red (Invitrogen) diluted in culture medium 586 
(final concentration of 300 μM) was added to the respective wells and incubated for 15 587 
min at 37°C. In order to stain ER and golgi apparatus of transfected cells, cells were 588 
fixed with 4% PFA for 25 min followed by permeabilization with 0.1% Triton-X100 for 2 589 
min. Subsequently, cells were stained with ConA (20 μg/ml) and WGA (5 μg/ml) for 25 590 
min at RT. Stained cells were washed once with PBS and once with H2O. Finally, a drop 591 
of Roti-Mount FluorCare DAPI was overlaid and the cells were covered with a glass 592 
coverslip before being analyzed using confocal microscope at respective wavelengths, 593 
EYFP: 488 nm; ConA: 594 nm; WGA: 594 nm; Mitotracker deep red: 633 nm. Images 594 
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were taken which were analyzed using Imaris software. To quantify the amount of co-595 
localization, a previously established method (Manders’ overlap coefficient) was used 596 
(28). 597 
Fluorescent stains 598 
The following fluorescent stains were used: Roti-Mount FluorCare DAPI (Carl Roth 599 
GmbH, Karlsruhe, Germany), Mitotracker deep red (633 nm; Invitrogen, Carlsbad, CA, 600 
USA), ConA-Alexa-594, WGA-Alexa-594, FITC annexin V (AV) (Abcam, Cambridge, 601 
UK) and propidium iodide (P.I.) (Sigma-Aldrich, St. Louis, MI, USA). 602 
Annexin/PI staining 603 
Vero 2-2 cells were seeded in 6 wells plate at the confluency of 90%. Next day, cells 604 
were either left non-transfected or transfected with respective plasmids. After either 48 h 605 
or 72 h, cells were harvested and washed once with PBS. Working dilution (100 μg/ml) 606 
of Propidium iodide (PI) (Sigma-Aldrich Chemie GmbH, Buchs SG, Switzerland) was 607 
prepared. Then 2 μl of FITC annexin V (Abcam, Cambridge, UK) and 1 μl of PI (from 608 
working dilution) was added to 100 μl of 1X annexin-binding buffer. Washed cells were 609 
re-suspended in 100 μl of 1X annexin-binding buffer and incubated for 15 min in dark. 610 
Then the cells were filtered through polystyrene round bottom FACS tube with cell-611 
strainer cap (BD Falcon) and data was acquired using Flow cytometry. Three different 612 
channels were used. FL1: EYFP, FL4: PI and FL6: Cy5. The acquired data were 613 
analyzed using Kaluza analysis (Beckman Coulter). 614 
Purified antibodies against Ov8.25 protein 615 
A rabbit anti-peptide serum was commercially produced and purified by GenicBio 616 
Limited, Sanghai, China. The immunizing synthetic peptide (KKKDKKRDEDEDEDEDE-617 
C) was conjugated to KLH. Specific antibodies were purified from the resulting 618 
antiserum using peptide-specific affinity. 619 
Pre-immune serum (2 ml), purified antibodies (4 mg) as well as 10 mg of unconjugated 620 
peptide were provided in lyophilized form.  621 
Immunohistochemistry 622 
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Due to the scarcity of the disease, tissues from fresh MCF cases were unavailable. As 623 
an alternative, we took advantage of an existing collection of formaldehyde-fixed, 624 
paraffin embedded brain tissues from suspected BSE cases, which, though, had been 625 
deemed BSE-negative but whose pathological diagnosis was encephalitis, probably due 626 
to viral origin. One of those cases (#44282 from 2010; thalamus) had been deemed 627 
OvHV2-positive by PCR, whereas two other cases (# 33181 from 2001; brain stem and 628 
# 26731 from 1998; brain stem) had been deemed negative for OvHV-2. In the fourth 629 
case (#51194 from 2018; brain stem), listeriosis had been diagnosed but OvHV-2 was 630 
not formally excluded on fresh tissue. The brain tissues were cut into 3μm sections. 631 
After antigen retrieval by boiling the samples for 20 minutes in a microwave in the 632 
presence of the antigen retrieval buffer (LSAB™, DAKO), the sections were incubated 633 
over-night at 4°C with either the purified Rabbit-anti-pOv8.25 serum or else with 634 
peptide-saturated antiserum. Subsequently, the reactions were made visible using a 635 
streptavidin–biotin-complex method (LSAB™, DAKO) and AEC as chromogen.  636 
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Figure legends 759 
Fig. 1. RACE experiments to determine the ends of the novel transcript. 1% 760 
agarose gel showing RLM-RACE PCR products obtained from RNA of an MCF-affected 761 
cow. Lane 1: 3’RACE after first amplification. Lane 2: 3’RACE after nested amplification. 762 
Lane 3: 5’RACE after first amplification. Lane 4: 5’RACE after nested amplification. 763 
Lane 5: 1 kb DNA marker  764 
Fig. 2. Conservation of Ov8.25 locus and splicing. Sequence alignment of the novel 765 
transcripts found in the LGLs (RNA_lgl) and in lymphocytes of a cow with MCF 766 
(RNA_cow) against published OvHV-2 genomic sequences. The predicted translation 767 
initiation codon (ATG) is highlighted in bold letters. The two predicted introns in the 768 
processed transcripts are highlighted in red. The asterisks indicate identical nucleotides 769 
in all four sequences. The internal gene-specific primers used for RACE are highlighted 770 
in blue. The sequences of the forward primers and the complementary sequences of the 771 
reverse primers, respectively, for cloning into the pEGFP N3 expression vector are 772 
highlighted in green.  773 
Fig. 3. The Ov8.25 transcript is smaller than its DNA template. Amplified PCR 774 
products on a 2.5% agarose gel with the DNA size marker in the lanes 1 and 6. The 775 
lanes 2, 3, and 4 show the PCR products obtained from decreasing amounts of cDNA 776 
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template (3.2 µl, 1.9 µl, 1.5 µl cDNA template, respectively). For lane 5, the transfecting 777 
DNA construct was used as template.  778 
Fig. 4. Compartmentalized localization of pOv8.25-EYFP fusion protein. Vero 2-2 779 
cells under the fluorescence microscope at 24 hrs after transfection with either 780 
pHSV_EGFP (A) or pHSV_Ov8.25-EYFP (B).  781 
Fig. 5. Conserved splicing of Ov8.25 transcripts. Reverse transcription PCR using 782 
RNA template, harvested at 24 hrs post transfection of Vero 2-2 cells with synthetic 783 
Ov8.25 amplicon constructs.  784 
Each construct is represented in three consecutive lanes and each triplet is labeled 785 
beneath the lanes with the designation of the construct. The first lane (lanes 2, 5, 8, 11, 786 
15) in each triplet represents a control using plasmid DNA as template. For the second 787 
lane (lanes 3, 6, 9, 12, 16), reverse transcribed RNA extract had been used as PCR 788 
template. For the third lane (lanes 4, 7, 10, 13, 17), RNA extract was PCR amplified 789 
without prior reverse transcriptase treatment. Lanes 1 and 14: 100 bp DNA size ladder, 790 
with a strong 500 bp band. 791 
Fig. 6. Predicted structure of pOv8.25, including M1, M51 (blue), two transmembrane 792 
domains, and predicted antibody epitope (yellow), which was used to generate a rabbit 793 
antiserum against pOv8.25.  794 
(Figure generated using protter (29))  795 
Fig. 7. Apparent mobility and solubility of pOv8.25. Western immunoblot of 796 
transfected Vero 2-2 cells. A, B, C) Labeled with anti-GFP monoclonal antibody. (A') 797 
Replicate blot, labeled with anti-actin monoclonal antibody. (B', C') Blots from B and C 798 
re-stained with anti-tubulin monoclonal antibody.  799 
Panels A, A') Lane M: molecular weight marker. Blue band labeled on the left: 35 kDa. 800 
Lanes 1-4: transfected cell extracts, harvested at 24 hrs. Lane 1: EYFP-amplicon; lane 801 
2: codon-optimized, intronless Ov8.25 coding sequence with C-terminal EYFP; lane 3: 802 
codon-optimized Ov8.25 locus with C-terminal EYFP. Lane 4: untransfected cell extract.  803 
Panels B, B', C, C') Harvested cells were suspended in IP buffer containing 1% Triton 804 
X100, before soluble and insoluble extracts were separated by centrifugation. 805 
Both fractions were separately taken up in SDS buffer a separated by PAGE. Finally, 806 
Western transfers were stained using monoclonal antibodies. Lanes 1: non-transfected 807 
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Vero cells. Lanes 2-6: transfected Vero cells. 2: transfected with EYFP; 3: codon-808 
optimized Ov8.25 locus with C-terminal EYFP; 4: codon-optimized, intronless Ov8.25 809 
coding sequence with C-terminal EYFP; 5: 5'-truncated codon-optimized Ov8.25 locus 810 
with C-terminal EYFP; 6: 5'-truncated codon-optimized, intronless Ov8.25 coding 811 
sequence with C-terminal EYFP. 812 
Red arrow indicating 38.7 kDa, the predicted mobility of pOv8.25-EYFP fusion protein.  813 
Fig. 8. Identification of pOv8.25 by anti-peptide serum. Western immunoblots of 814 
insoluble cell extracts. Panel A) Labeled with rabbit anti pOv8.25 serum. Panel B) 815 
Labeled with anti-GFP monoclonal antibody. C) Labelled with antibody that was 816 
primarily saturated with immunizing peptide. 817 
Lane M: Page ruler plus, molecular weight marker. MWs indicated on the left. Lane 1: 818 
non-tranfected Vero cells; Lane 2: transfected with EYFP; Lane 3: transfected with 819 
codon-optimized Ov8.25 locus with C-terminal EYFP; Lane 4: transfected with codon-820 
optimized, intronless Ov8.25 coding sequence C-terminal EYFP; Lane 5: truncated 821 
version of codon-optimized Ov8.25 locus with C-terminal EYFP; Lane 6: truncated 822 
version of codon-optimized, intronless Ov8.25 coding sequence C-terminal EYFP. 823 
Red arrows in A) and B) pointing to 38.7 kDa, the predicted mobility of pOv8.25-EYFP 824 
fusion protein.  825 
Note: higher molecular bands are recognized by both the rabbit anti-peptide serum and 826 
the anti-GFP mcAb. The EYFP band (lane 2) is not recognized by the rabbit anti-peptide 827 
serum. 828 
Fig. 9. pOv8.25-EYFP co-localizes with the mitotracker stain. Vero cells were 829 
transfected with either Ov8.25-EYFP amplicon DNA (panels A through F) or with a 830 
truncated version, which is translated only from the ATG encoding for M51 of the 831 
original aa sequence (panels G through I). The cells were fixed at 24 hrs before being 832 
stained with DAPI and analyzed by confocal microscopy. Panels A, D and G show 833 
yellow fluorescence and DAPI, panels B, E and H show the mitotracker stain and DAPI. 834 
Co-localization of EYFP and red fluorescence (mitotracker), indicated by yellow, was 835 
addressed in panels C, C', F and I. C' shows a three-dimensional reconstruction of the 836 
cell presented in C. The bar in C', F and I represent 10 µm, 20 µm and 30 µm 837 
respectively. 838 
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Fig. 10. pOv8.25-EYFP fusion protein co-localizes predominantly with 839 
mitochondria. Vero cells were transfected with Ov8.25-EYFP amplicon DNA and were 840 
stained with WGA (panels B, C), red fluorescent Mitotracker (panels E, F) and ConA 841 
(panels H, I) in order to test co-localization of pOv8.25-EYFP with individual membrane 842 
compartments. (A) Confocal images, supplemented with DAPI stain to show the cell 843 
nuclei (blue). Membrane staining is seen in red; yellow fluorescence appears in green; 844 
co-localization appears in yellow. The bar represents 30um. (B) Quantitative analysis of 845 
the co-localization at 6, 24, and 48 hrs post transfection (Determination of the Mander’s 846 
coefficient described in Materials and Methods). 847 
Fig. 11. Synthesis of pOv8.25 is associated with increased cell death in a Bovine 848 
Treg-like cell line. Tp951-f53 cells were left non-transduced (panels A) or were 849 
transduced with either EGFP (panels B, B’) or Ov8.25 constructs (Ov8.25L-EYFP in 850 
panels C, C’; Ov8.25CDS-EYFP in panels D, D’). After 24 hrs, the cells were harvested, 851 
double-stained annexin-V and propidium iodide, and gated for fluorescence due to GFP 852 
or EYFP. 853 
Panel (A-D) show the total cells where gate C shows the population that has been gated 854 
for EYFP expression. 855 
Panel (B’-D’) show the AV/PI staining of gated population. 856 
Fig 12: Flow cytometry analysis of AV-CY5/PI double stained and EYFP-gated 857 
cells. Vero 2-2 cells were transfected with either V5_EYFP (A,F) or Ov8.25L_EYFP 858 
(B,G) or Ov8.25CDS_EYFP (C,H) or TOv8.25_EYFP (D,I) or TOv8.26CDS_EYFP (E,J). 859 
Cells harvested at 48 and 72 hrs post transfection were labelled with AV-Cy5 and PI 860 
and analyzed by flow cytometry. Cells gated for EYFP-expression are shown. AV 861 
negative /PI negative (B--): Viable cells; AV positive /PI negative (B+-): apoptotic cells; 862 
AV positive/PI positive (B++): late apoptotic/dead cells. 863 
Fig. 13. Caspase-dependent cell death upon transient expression of Ov8.25. Vero 864 
cells were transfected with constructs encoding for Ov8.25-EYFP fusion proteins or 865 
EYFP alone and incubated either in the presence or absence of a broad-spectrum 866 
caspase inhibitor. The cells were harvested after 48 and 72 hrs, respectively, and 867 
stained for AV and PI before being gated for yellow fluorescence. (A) The counts of 868 
EYFP-positive, gated cells in each of the five experiments are shown, separately for 869 
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cells that had been incubated in the absence (dots) or presence (squares) of the 870 
inhibitors as well as for 48 hrs or 72 hrs post transfection. Panels B and C show the 871 
medium values and standard deviations from five independent experiments, depicting 872 
the proportions of viable (AV/PI-double negative) cells at 48 hrs (B) or 72 hrs (C). Panel 873 
D shows the proportions of early apoptotic cells at 48 hrs (AV-positive/PI-negative); 874 
Panel E the proportions of late apoptotic cells at 72 hrs (AV/PI double positive). Each 875 
column in a panel, representing replicate values from five independent experiments, 876 
was compared individually to each other column in the same panel. Significant 877 
differences were detected using the unpaired t test (**** indicates a p value of <0.0001). 878 
Fig. 14. Detection of pOv8.25 in MCF-like lesions. Sections of brain tissues from 879 
cattle with encephalitis were immune-stained with the rabbit anti-pOv8.25 peptide 880 
serum. Positive reactions (Panels A and B) show reddish coloration due to the AEC 881 
chromogen in two independent cases, one of which had previously deemed positive for 882 
OvHV-2 by PCR. Areas with typical staining are magnified in A’ and B’. Panels C and D 883 
show samples from two additional unrelated cases, which did not show positive 884 
reactions and which had previously been deemed negative for OvHV-2 by PCR. 885 
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Tables 887 
Tab. 1. Primer sequences for RLM-RACE 888 
 889 
Primer Sequence (5’-3’) Target 
5’-RACE outer 
forward 
GCT GAT GGC GAT GAA TGA ACA CTG 5’ adapter 
5’-RACE inner 
forward 
CGC GGA TCC GAA CAC TGC GTT TGC TGG CTT 
TGA TG 
5’ adapter 
5’-RACE inner 
reverse 
TGA ATT AGG AGG CGA CCG TA OvHV2-
specific 
5’-RACE outer 
reverse 
AGA TTG CCA TCT GGG AGG TT OvHV2-
specific 
3’-RACE outer 
forward 
TAC GGT CGC CTC CTA ATT CA OvHV2-
specific 
3’-RACE inner 
forward 
GAT GGC AAT CTG CAA CCT TA OvHV2-
specific 
3’-RACE inner 
reverse 
CGC GGA TCC GAA TTA ATA CGA CTC ACT 
ATA GG 
3’ adapter 
3’-RACE outer 
reverse 
GCG AGC AGA ATT AAT ACG ACT 3’ adapter 
 890 
 891 
Tab. 2. Primer sequences for cloning into pEGFP N3 expression vector and transient 892 
expression. 893 
 894 
Primer Sequence (5’-3’)a Target 
Forward Ov8.25 locus tcagg/ctagcAGTAAGCACACAGAAGGGAG 5’ of 8.25 locus 
with NheI site 
Reverse Ov8.25 locus ggacc/ggccgGGACACTCATATTAATTAAA
ACATTTATTTAC 
3’ of 8.25 locus 
with EagI site 
Forward Ov8.25 intron CCTGCTCATAATTATCTTTGCG 5’ of first intron 
Reverse Ov8.25 intron TCCTCATCCTCATCTCTCTTCTT 3’ of last intron 
a non-OvHV-2 sequences in small letters and italics. 895 
 896 
  897 
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Tab. 3. Overview of synthetic constructs. 898 
 899 
Designation Description Purpose 
Synthetic Ov8.25 
locus 
Reverse translated from the native aa sequence 
as determined from a Swiss cow with MCF, 
starting from M-codon of the predicted protein 
and ending prior to the STOP codon. Exon 
sequences codon-optimized for translation in 
bovine cells; unaltered introns sequences; 
additional 5’ and 3’ nucleotides to provide 
Restriction enzyme sites for orientation-
dependent subcloning 
Transient 
expression of an 
EYFP-fusion 
protein; 
translated from 
mRNA after 
splicing 
M-less Ov8.25 Same as above but each ATG in the exons of 
ORF1 replaced by a STOP codon; intron 
sequences remained native 
Transient 
expression of 
EYFP without 
preceding 
pOv8.25; 
translated from 
mRNA after 
splicing 
M-less intron 1 
Ov8.25 
Shorter version of the above, flanking intron 1 Confirmation of 
splice sites 
M-less intron 2 
Ov8.25 
Similar as above but flanking intron 2 Confirmation of 
splice sites 
Ov8.25 CDS Intronless coding sequences of pOv8.25 
without STOP codon; codon-optimized for 
translation in bovine cells 
Phenotype of the 
EYFP-fusion 
protein in the 
absence of 
splicing 
 900 
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